AAM
MYOK

Aberdeen Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Aberdeen Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20,549
Closed -$270K – 768
2017
Q1 		$270K Buy
20,549
+9,451
+85% +$121K ﹤0.01% 727
2016
Q4 		$144K Buy
+11,098
New +$171K ﹤0.01% 739

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Aberdeen Asset Management's MYOK Position: Q2 2017 in Review

Aberdeen Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2017, closing a stake of 20,549 shares — an estimated $270K sold.

Aberdeen Asset Management first reported a position in MYOK in Q4 2016 and held it in 2 quarters. The position peaked at $270K in Q1 2017. 75 funds tracked by Wall St. Rank hold MYOK as of Q2 2017.

  • Aberdeen Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Aberdeen Asset Management sold 20,549 MyoKardia, Inc. Common Stock shares in Q2 2017, an estimated $270K.
  • Aberdeen Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 2 quarters.
  • Aberdeen Asset Management's MyoKardia, Inc. Common Stock position peaked at $270K in Q1 2017.
  • 75 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.